Abstract:Organoids offer a powerful model to study cellular self-organisation, the growth of specific tissue morphologies in-vitro , and to assess potential medical therapies. However, the intrinsic mechanisms of these systems are not entirely understood yet, which can result in variability of organoids due to differences in culture conditions and basement membrane extracts used. Improving the standardisation of organoid cultures is essential for their implementation in clinical protocols. Developing tools to assess and predict the behaviour of these systems may produce a more robust and standardised biological model to perform accurate clinical studies. Here, we developed an algorithm to automate crypt-like structure counting on intestinal organoids in both in-vitro and in-silico images. In addition, we modified an existing two-dimensional agent-based mathematical model of intestinal organoids to better describe the system physiology, and evaluated its ability to replicate budding structures compared to new experimental data we generated. The crypt-counting algorithm proved useful in approximating the average budding structures found in our in-vitro intestinal organoid culture images on days 3 and 7 after seeding. Our changes to the in-silico model maintain the potential to produce simulations that replicate the number of budding structures found on days 5 and 7 of in-vitro data. The present study aims to aid in quantifying key morphological structures and provide a method to compare both in-vitro and in-silico experiments. Our results could be extended later to 3D in-silico models. Organoids offer a powerful biological model to study cellular self-organisation, the growth of specific tissue formation, and to assess potential medical therapies. However, many different organoid shapes can be observed in practice, and the mechanisms underlying their generation are not yet fully understood. This means that it is still a challenge to standardise organoid cultures for experimental manipulation, and hence to derive the maximum benefit for understanding human health and disease. Mathematical models offer a potential solution to this problem, although the question remains of how to use data of lab-grown organoids to properly calibrate and test the models, given the number and complexity of the images generated by both in-vitro and in-silico experiments. In this paper we aim to address this question. We develop methods that can automatically extract the key morphological features from collections of intestinal organoids images—specifically, to count budding structures—generated from both new in-vitro experiments and in-silico simulations. Experimental results are compared to simulations of a multiscale mathematical model which describes the system physiology and can replicate the budding structures that are seen experimentally.

Mass Spectrometry Imaging and Histology for the Analysis of Budding Intestinal Organoids

Mass Spectrometry Imaging of Organoids to Improve Pre‐Clinical Research

Rapid Whole-Organ Characterization Via Quantitative Light-Sheet Microscopy

Molecular Imaging of Human Brain Organoids Using Mass Spectrometry

MS imaging of multicellular tumor spheroids and organoids as an emerging tool for personalized medicine and drug discovery

Spatially lipidomic characterization of patient-derived organoids by whole-mount autofocusing SMALDI mass spectrometry imaging

High-resolution 3D imaging of fixed and cleared organoids

Mass spectrometry imaging as an emerging tool for studying metabolism in human brain organoids

Non-Invasive Label-free Analysis Pipeline for In Situ Characterization of Differentiation in 3D Brain Organoid Models

Non-invasive label-free imaging analysis pipeline for in situ characterization of 3D brain organoids

Lipidomic Phenotyping Of Human Small Intestinal Organoids Using Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry Imaging

Automated high-speed 3D imaging of organoid cultures with multi-scale phenotypic quantification

Long-term three-dimensional high-resolution imaging of live unlabeled small intestinal organoids via low-coherence holotomography

Histology-Guided Single-Cell Mass Spectrometry Imaging using Integrated Bright-field and Fluorescence Microscopy

Mass Spectrometry Imaging and Integration with Other Imaging Modalities for Greater Molecular Understanding of Biological Tissues

Mass spectrometry imaging methods for visualizing tumor heterogeneity

Analysis of organoid and immune cell co-cultures by machine learning-empowered image cytometry

A Strainer-Based Platform for the Collection and Immunolabeling of Mouse Intestinal Organoids

In-silico and in-vitro morphometric analysis of intestinal organoids

High-resolution 3D spatial distribution of complex microbial colonies revealed by mass spectrometry imaging

Quantification of Irinotecan in Single Spheroids Using Internal Standards by MALDI Mass Spectrometry Imaging